BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30662521)

  • 1. Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis.
    Kim HS; Kim JH; Jang HJ; Han B; Zang DY
    J Cancer; 2019; 10(1):20-27. PubMed ID: 30662521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic and prognostic impacts of
    Kim HS; Kim JH; Jang HJ
    J Cancer; 2019; 10(11):2560-2567. PubMed ID: 31258762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and pathological impact of tumor budding in gastric cancer: A systematic review and meta-analysis.
    Guo YX; Zhang ZZ; Zhao G; Zhao EH
    World J Gastrointest Oncol; 2019 Oct; 11(10):898-908. PubMed ID: 31662828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis.
    Razmi M; Ghods R; Vafaei S; Sahlolbei M; Saeednejad Zanjani L; Madjd Z
    Cancer Cell Int; 2021 Feb; 21(1):139. PubMed ID: 33639931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis.
    Yang Y; Gao P; Song Y; Sun J; Chen X; Zhao J; Ma B; Wang Z
    Eur J Surg Oncol; 2016 Aug; 42(8):1176-82. PubMed ID: 27293109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis.
    Kim JH; Jang HJ; Kim HS; Kim BJ; Park SH
    J Cancer; 2018; 9(19):3427-3434. PubMed ID: 30310499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis.
    Yin S; Li Z; Huang J; Miao Z; Zhang J; Lu C; Xu H; Xu H
    Onco Targets Ther; 2017; 10():319-327. PubMed ID: 28138255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
    Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
    PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
    Wu JX; Zhao YY; Wu X; An HX
    PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.
    Cheng F; Zeng C; Zeng L; Chen Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer.
    Murase H; Inokuchi M; Takagi Y; Kato K; Kojima K; Sugihara K
    Mol Clin Oncol; 2014 Jul; 2(4):509-517. PubMed ID: 24940486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
    Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
    Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.
    Ruan H; Hu S; Zhang H; Du G; Li X; Li X; Li X
    Oncotarget; 2017 Dec; 8(68):113163-113173. PubMed ID: 29348895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
    Ge H; Yan Y; Guo L; He X; Yang X
    Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of CD44 expression in gastric cancer: a meta-analysis.
    Chen Y; Fu Z; Xu S; Xu Y; Xu P
    Biomed Pharmacother; 2014 Jul; 68(6):693-7. PubMed ID: 25194445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological value of the geriatric nutritional risk index in gastric cancer: A meta-analysis of 5,834 patients.
    He L; Li Y; Qu L; Zhang F
    Front Surg; 2022; 9():1087298. PubMed ID: 36684163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis.
    Qiu Y; Zhang Z; Chen Y
    Front Oncol; 2021; 11():537140. PubMed ID: 33777726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.
    Song YX; Huang XZ; Gao P; Sun JX; Chen XW; Yang YC; Zhang C; Liu HP; Wang HC; Wang ZN
    Dis Markers; 2015; 2015():549843. PubMed ID: 26576068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.